High drug-loading nanomedicines: progress, current status, and prospects

药品 纳米医学 毒品携带者 材料科学 纳米技术 药物输送 药理学 纳米颗粒 医学
作者
Shihong Shen,Youshen Wu,Yongchun Liu,Daocheng Wu
出处
期刊:International Journal of Nanomedicine [Dove Medical Press]
卷期号:Volume 12: 4085-4109 被引量:444
标识
DOI:10.2147/ijn.s132780
摘要

Abstract: Drug molecules transformed into nanoparticles or endowed with nanostructures with or without the aid of carrier materials are referred to as “nanomedicines” and can overcome some inherent drawbacks of free drugs, such as poor water solubility, high drug dosage, and short drug half-life in vivo. However, most of the existing nanomedicines possess the drawback of low drug-loading (generally less than 10%) associated with more carrier materials. For intravenous administration, the extensive use of carrier materials might cause systemic toxicity and impose an extra burden of degradation, metabolism, and excretion of the materials for patients. Therefore, on the premise of guaranteeing therapeutic effect and function, reducing or avoiding the use of carrier materials is a promising alternative approach to solve these problems. Recently, high drug-loading nanomedicines, which have a drug-loading content higher than 10%, are attracting increasing interest. According to the fabrication strategies of nanomedicines, high drug-loading nanomedicines are divided into four main classes: nanomedicines with inert porous material as carrier, nanomedicines with drug as part of carrier, carrier-free nanomedicines, and nanomedicines following niche and complex strategies. To date, most of the existing high drug-loading nanomedicines belong to the first class, and few research studies have focused on other classes. In this review, we investigate the research status of high drug-loading nanomedicines and discuss the features of their fabrication strategies and optimum proposal in detail. We also point out deficiencies and developing direction of high drug-loading nanomedicines. We envision that high drug-loading nanomedicines will occupy an important position in the field of drug-delivery systems, and hope that novel perspectives will be proposed for the development of high drug-loading nanomedicines. Keywords: nanomedicines, nanocarriers, high drug loading, fabrication strategy, optimum proposal

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
白驹过隙完成签到 ,获得积分10
2秒前
熊雅完成签到,获得积分10
4秒前
橙子完成签到,获得积分20
15秒前
快乐学习每一天完成签到 ,获得积分10
16秒前
kyt_vip完成签到,获得积分10
16秒前
17秒前
如意语山完成签到 ,获得积分10
18秒前
CRUSADER发布了新的文献求助10
24秒前
鱼儿游完成签到 ,获得积分10
27秒前
DZS完成签到 ,获得积分10
27秒前
甜甜的tiantian完成签到 ,获得积分10
28秒前
月上柳梢头A1完成签到,获得积分10
30秒前
象象完成签到 ,获得积分10
33秒前
外科老白完成签到,获得积分10
34秒前
BiangBiang完成签到,获得积分10
36秒前
CRUSADER完成签到,获得积分10
43秒前
allen1994完成签到,获得积分10
44秒前
Kao应助科研通管家采纳,获得10
44秒前
打打应助科研通管家采纳,获得10
44秒前
Kao应助科研通管家采纳,获得10
45秒前
Kao应助科研通管家采纳,获得10
45秒前
Kao应助科研通管家采纳,获得10
45秒前
Kao应助科研通管家采纳,获得10
45秒前
李秋莉完成签到 ,获得积分10
45秒前
51秒前
54秒前
甜甜的粥发布了新的文献求助10
56秒前
jennawu完成签到 ,获得积分10
56秒前
凌泉完成签到 ,获得积分10
59秒前
蟑先生完成签到 ,获得积分10
1分钟前
houshyari发布了新的文献求助10
1分钟前
无忧的阳光完成签到 ,获得积分20
1分钟前
houshyari完成签到,获得积分20
1分钟前
又又完成签到,获得积分10
1分钟前
CipherSage应助Wang采纳,获得10
1分钟前
贪玩定帮完成签到,获得积分10
1分钟前
Robin完成签到 ,获得积分10
1分钟前
简奥斯汀完成签到 ,获得积分10
1分钟前
甜甜的粥完成签到,获得积分10
1分钟前
笨笨忘幽完成签到,获得积分0
1分钟前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7282297
求助须知:如何正确求助?哪些是违规求助? 8903122
关于积分的说明 18833851
捐赠科研通 6953259
什么是DOI,文献DOI怎么找? 3207556
关于科研通互助平台的介绍 2377841
邀请新用户注册赠送积分活动 2182729